New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis
The Cystic Fibrosis Foundation's successful business model was at the center of a congressional briefing in Washington, D.C., today, which focused on strategies for jump-starting drug development for rare diseases.
|
2 min read